Biotech News
Sensei Biotherapeutics Reports Third Quarter 2025 Financial Results
investors.senseibio.com2026-05-06 15:13 EST
BOSTON, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, today reported financial results for the third quarter 2025.